​

Lantheus (LNTH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LNTH Stock Forecast

Lantheus (LNTH) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $159.00, with a high of $175.00 and a low of $143.00. This represents a 75.81% increase from the last price of $90.44.

$50 $80 $110 $140 $170 $200 High: $175 Avg: $159 Low: $143 Last Closed Price: $90.44

LNTH Stock Rating

Lantheus stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 6 Strong Sell Sell Hold Buy Strong Buy

LNTH Price Target Upside V Benchmarks

TypeNameUpside
StockLantheus75.81%
SectorHealthcare Stocks 25.00%
IndustrySpecialty & Generic Drug Manufacturers Stocks28.73%

Price Target Trends

1M3M12M
# Anlaysts-14
Avg Price Target-$143.00$152.00
Last Closing Price$90.44$90.44$90.44
Upside/Downside-58.12%68.07%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 25391--13
Jan, 25391--13
Dec, 24391--13
Nov, 24291--12
Oct, 24291--12
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 18, 2024Paul ChoiGoldman Sachs$143.00$91.1556.88%58.12%
Sep 03, 2024Ed Ridley-DayRedburn Partners$175.00$106.4764.37%93.50%
Aug 01, 2024David TurkalyJMP Securities$125.00$104.8319.24%38.21%
Jul 12, 2024Anthony PetroneMizuho Securities$165.00$123.6233.47%82.44%
Nov 15, 2022Leerink Partners$120.00$57.25109.61%32.68%
Aug 05, 2022Leerink Partners$110.00$76.2544.26%21.63%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 18, 2024Goldman SachsBuyBuyinitialise
Sep 16, 2024Cowen & Co.BuyBuyhold
Aug 01, 2024JMP SecuritiesOutperformOutperformhold
Jul 25, 2024B. RileyBuyBuyhold
Jul 10, 2024JMP SecuritiesOutperformOutperformhold
May 03, 2024Mizuho SecuritiesUnderperformUnderperformhold
Apr 18, 2024B. RileyBuyBuyhold
Feb 23, 2024Cowen & Co.UnderperformUnderperformhold
Nov 15, 2022SVB LeerinkOutperformOutperformhold
Oct 07, 2022Goldman SachsBuyBuyhold

Financial Forecast

EPS Forecast

$-5 $-1 $3 $7 $11 $15 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.25$-1.06$0.41$4.79-----
Avg Forecast$0.45$0.41$3.84$5.92$6.74$7.01$7.82$8.73$11.28
High Forecast$0.44$0.40$3.67$5.79$6.65$6.52$6.52$7.34$10.57
Low Forecast$0.48$0.44$4.10$6.01$6.94$7.66$9.11$10.70$12.41
Surprise %-155.56%-358.54%-89.32%-19.09%-----

Revenue Forecast

$0 $600M $1B $2B $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$339.41M$425.21M$935.06M$1.30B-----
Avg Forecast$337.51M$407.40M$916.62M$1.28B$1.52B$1.61B$1.81B$2.10B$2.52B
High Forecast$327.54M$395.37M$887.05M$1.27B$1.51B$1.53B$1.81B$2.09B$2.40B
Low Forecast$353.31M$426.48M$966.08M$1.29B$1.54B$1.73B$1.82B$2.10B$2.71B
Surprise %0.56%4.37%2.01%1.13%-----

Net Income Forecast

$-100M $100M $300M $500M $700M $900M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-13.47M$-71.28M$28.07M$326.66M-----
Avg Forecast$-30.15M$6.98M$33.67M$326.66M$477.52M$498.28M$517.16M$655.29M$792.30M
High Forecast$-37.07M$-14.33M$12.11M$67.86M$467.36M$458.27M$458.12M$515.43M$742.59M
Low Forecast$-23.23M$28.28M$55.24M$585.46M$487.68M$538.30M$639.92M$751.74M$871.79M
Surprise %-55.31%-1121.86%-16.65%------

LNTH Forecast FAQ

Is Lantheus stock a buy?

Lantheus stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Lantheus is a favorable investment for most analysts.

What is Lantheus's price target?

Lantheus's price target, set by 6 Wall Street analysts, averages $159 over the next 12 months. The price target range spans from $143 at the low end to $175 at the high end, suggesting a potential 75.81% change from the previous closing price of $90.44.

How does Lantheus stock forecast compare to its benchmarks?

Lantheus's stock forecast shows a 75.81% upside, outperforming the average forecast for the healthcare stocks sector (25.00%) and outperforming the specialty & generic drug manufacturers stocks industry (28.73%).

What is the breakdown of analyst ratings for Lantheus over the past three months?

  • February 2025: 23.08% Strong Buy, 69.23% Buy, 7.69% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 23.08% Strong Buy, 69.23% Buy, 7.69% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 23.08% Strong Buy, 69.23% Buy, 7.69% Hold, 0% Sell, 0% Strong Sell.

What is Lantheus’s EPS forecast?

Lantheus's average annual EPS forecast for its fiscal year ending in December is $6.74 for 2024, a 40.71% increase from the reported $4.79 in 2023. The prediction for 2025 is $7.01, $7.82 for 2026, $8.73 for 2027, and $11.28 for 2028.

What is Lantheus’s revenue forecast?

Lantheus's average annual revenue forecast for its fiscal year ending in December is $1.52B for 2024, a 17.28% increase from the reported $1.3B in 2023. The forecast for 2025 is $1.61B, $1.81B for 2026, $2.1B for 2027, and $2.52B for 2028.

What is Lantheus’s net income forecast?

For its fiscal year ending in December, Lantheus's average annual net income forecast is $477.52M for 2024, reflecting an 46.18% increase from the reported $326.66M in 2023. The projection for 2025 is $498.28M, $517.16M for 2026, $655.3M for 2027, and $792.3M for 2028.